Consort has recently completed the acquisition of Aesica Holdco. Jon Glenn, Chief Executive Officer, Consort said, “We are excited by the acquisition of Aesica which represents a very strong fit with our existing strategy of diversifying into adjacent markets and technologies to capture additional value in the drug/ device supply chain. As one of Europe’s leading pharmaceutical CDMOs, Aesica is highly complementary to Bespak’s existing business and provides a number of clear strategic, competitive and value-enhancing benefits for the Enlarged Group.”
EP News Bureau – Mumbai